These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 63738)

  • 1. Therapy-linked leukemia.
    Chang J; Geary CG
    Lancet; 1977 Jan; 1(8002):97. PubMed ID: 63738
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic therapy for Wegener's granulomatosis.
    Morton CE; Easton DJ
    Lancet; 1984 Jun; 1(8391):1411. PubMed ID: 6145861
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary acute myeloblastic leukemia with a Ph translocation in a treated Wegener's granulomatosis.
    Ohyashiki K; Kocova M; Ryan DH; Rowe JM; Sandberg AA
    Cancer Genet Cytogenet; 1986 Jan; 19(3-4):331-3. PubMed ID: 3455848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis.
    Calatroni M; Buzio C; Vaglio A
    Rheumatology (Oxford); 2015 Aug; 54(8):1339-41. PubMed ID: 26018438
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow transplantation with a reduced-intensity conditioning regimen in a patient with Wegener granulomatosis and therapy-related leukemia.
    Kunitomi A; Ishikawa T; Tajima K; Konaka Y; Yagita M
    Int J Hematol; 2006 Apr; 83(3):262-5. PubMed ID: 16720560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide-induced hepatitis in Wegener's granulomatosis.
    Du LT; Rigaud D; Papo T; Godeau P
    Mayo Clin Proc; 1994 Sep; 69(9):912-3. PubMed ID: 8065199
    [No Abstract]   [Full Text] [Related]  

  • 7. Does hepatocellular carcinoma develop after treatment of Wegener's granulomatosis with cyclophosphamide?
    Ueno T; Sata M
    Intern Med; 2003 May; 42(5):379-80. PubMed ID: 12793704
    [No Abstract]   [Full Text] [Related]  

  • 8. Myeloblastic leukemia following cyclophosphamide therapy of plasma cell dyscrasia.
    Pariser S
    N Y State J Med; 1974 Oct; 74(11):2016-20. PubMed ID: 4528651
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute myelogenous leukemia in myelomatosis].
    Tidsskr Nor Laegeforen; 1977 Feb; 97(4):175-7. PubMed ID: 265102
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
    Faurschou M; Mellemkjaer L; Voss A; Keller KK; Hansen IT; Baslund B
    Rheumatology (Oxford); 2015 Aug; 54(8):1345-50. PubMed ID: 25234661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity following cyclophosphamide treatment in a patient with MPO-ANCA vasculitis.
    Martínez-Gabarrón M; Enríquez R; Sirvent AE; García-Sepulcre M; Millán I; Amorós F
    Nefrologia; 2011; 31(4):496-8. PubMed ID: 21738257
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy-linked leukaemia.
    Geary CG
    Lancet; 1976 Oct; 2(7990):862. PubMed ID: 61545
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute myelogenous leukemia following immunosuppressive therapy for rheumatoid arthritis.
    Kapadia SB; Kaplan SS
    Am J Clin Pathol; 1978 Aug; 70(2):301-2. PubMed ID: 279231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide-induced hepatotoxicity in a patient with Wegener's granulomatosis.
    Snyder LS; Heigh RI; Anderson ML
    Mayo Clin Proc; 1993 Dec; 68(12):1203-4. PubMed ID: 8246624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcome.
    Knight A; Hjorton K; Sundström C; Höglund M; Backlin C; Smedby KE; Askling J; Baecklund E
    J Rheumatol; 2015 Apr; 42(4):690-4. PubMed ID: 25641890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wegener's granulomatosis.
    Sneller MC
    JAMA; 1995 Apr; 273(16):1288-91. PubMed ID: 7715042
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiomyopathy following intravenous cyclophosphamide therapy in a patient with Wegener's granulomatosis.
    Manthorpe R; Svensson O
    Clin Exp Rheumatol; 1996; 14(6):702-3. PubMed ID: 8978974
    [No Abstract]   [Full Text] [Related]  

  • 18. Subglottic stenosis in Wegener's granulomatosis: development during cyclophosphamide treatment with response to carbon dioxide laser therapy.
    Strange C; Halstead L; Baumann M; Sahn SA
    Thorax; 1990 Apr; 45(4):300-1. PubMed ID: 2113320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Wegener's granulomatosis: good regression in the thorax picture after cyclophosphamide therapy].
    Dietz R; Mall W; Austgen M; Lutz W
    Rofo; 1979 Sep; 131(3):325-7. PubMed ID: 161273
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide therapy in Wegener's granulomatosis.
    Novack SN; Pearson CM
    N Engl J Med; 1971 Apr; 284(17):938-42. PubMed ID: 5551803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.